The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kalugina A.S.

Department of Obstetrics, Gynecology, and Neonatology, Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia, Saint Petersburg, Russia;
Ava-Peter Clinic, Saint Petersburg, Russia

Bobrov K.Yu.

AVA-PETER clinic, St.-Petersburg, Russia, 191186

Polycyctic ovary syndrome: modern view and it’s role in  infertility (a review)

Authors:

Kalugina A.S., Bobrov K.Yu.

More about the authors

Journal: Russian Journal of Human Reproduction. 2015;21(2): 31‑35

Read: 3117 times


To cite this article:

Kalugina AS, Bobrov KYu. Polycyctic ovary syndrome: modern view and it’s role in  infertility (a review). Russian Journal of Human Reproduction. 2015;21(2):31‑35. (In Russ.)
https://doi.org/10.17116/repro201521231-35

Recommended articles:
Medi­cal and social characteristics of mate­rnal deaths after extracorporeal fertilization. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):5-14
The role of pelvic inflammatory diseases in reproductive function diso­rders in women. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):48-54

References:

  1. Artifeksov S.B. i dr. Osobennosti sovremennoi demograficheskoi situatsii v Rossii. Materialy 17-i ezhegodnoi mezhdunarodnoi konferentsii RARCh. Reproduktivnye tekhnologii segodnya i zavtra. 2007.
  2. Kulakov V.I. i dr. Lechenie muzhskogo i zhenskogo besplodiya. Pod red. Kulakova V.I., Leonova B.V., Kuz'micheva L.N. M.: MIA. 2005;592.
  3. Siristatidis C. et al. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction 2013. Cochrane Database Syst Rev. 2013;Oct 8;10:CD006606. doi: 10.1002/14651858.CD006606.pub3.
  4. Sirmans S, Pate K. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013 Dec 18;6:1-13.
  5. Drosdzol-Cop A. et al. Diagnosing polycystic ovary syndrome in adolescent girls. Ginekol Pol. 2014 Feb;85(2):145-148.
  6. Azziz R. Controversy in clinical endocrinology: diagnosis of polycyctic ovarian syndrome: The Rotterdam criteria are premature. J Clin Endocrinol Metab. 2006;91:781-785.
  7. Norman RJ. et al. Polycyctic ovary syndrome. Lancet. 2007;370:685-697.
  8. Dewailly D. et al. Diagnostika sindroma polikistoznykh yaichnikov (SPKYa): eshche raz o porogovykh znacheniyakh chisla follikulov (po dannym ul'trazvukovogo issledovaniya) i urovnya AMG v syvorotke, opredelyayushchikh nalichie SPKYa. Human Reproduction. 2011;6(24):22-30.
  9. Fauser BC. et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012 Jan;97(1):28-38.
  10. Dedov I.I., Mel'nichenko G.A. Sindrom polikistoznykh yaichnikov. M.: MIA. 2007;361.
  11. Corbett S, Morin-Papunen L. The Polycystic Ovary Syndrome and recent human evolution. Mol Cell Endocrinol. 2013 Jul 5;373(1-2):39-50.
  12. Yildiz BO, Azziz R. Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society. Fertil Steril. 2010 Jul;94(2):690-693.
  13. Dumesic DA, Richards JS. Ontogeny of the ovary in polycystic ovary syndrome. Fertil Steril. 2013 Jul;100(1):23-38.
  14. Ben-Shlomo I, Younis JS. Basic research in PCOS: are we reaching new frontiers? Reprod Biomed Online. 2014 Jun;28(6):669-683.
  15. Roland AV, Moenter SM. Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: Insight from animal models. Front Neuroendocrinol. 2014 Apr 18.
  16. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010 Jun 30;8:41.
  17. Setji TL, Brown AJ. Polycystic ovary syndrome: update on diagnosis and treatment. Am J Med. 2014 May 21. pii: S0002-9343(14)00356-8.
  18. Catteau-Jonard S, Dewailly D. Pathophysiology of polycystic ovary syndrome: the role of hyperandrogenism. Front Horm Res. 2013;40:22-27.
  19. Livadas S, Diamanti-Kandarakis E. Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach. Front Horm Res. 2013;40:1-21.
  20. Wang S, Alvero R. Racial and ethnic differences in physiology and clinical symptoms of polycystic ovary syndrome. Semin Reprod Med. 2013 Sep;31(5):365-369.
  21. Azziz R, Woods KS, Reyna R. The prevalence and features of the polycystic ovary syndrome in an uncelected population. JCE&M.2004;89(6):2745-2749.
  22. Artini PG. et al. Best methods for identification and treatment of PCOS. Minerva Ginecol. 2010 Feb;62(1):33-48.
  23. Azziz R. et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009 Feb;91(2):456-488.
  24. Merino P, Schulin-Zeuthen C, Codner E. Current diagnosis of polycystic ovary syndrome: expanding the phenotype but generating new questions. Rev Med Chil. 2009Aug;137(8):1071-1080.
  25. Domecq JP. et al. Lifestyle modification programs in polycystic ovary syndrome: systematic reviewand metaanalysis. J Clin Endocrinol Metab. 2013 Dec;98(12):4655-4663.
  26. Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health. 2011 Feb 8;3:25-35.
  27. Perales-Puchalt A, Legro RS. Ovulation induction in women with polycystic ovary syndrome. Steroids. 2013 Aug;78(8):767-772.
  28. Kostov I, Ingilizova G. In vitro maturation--a potential approach of infertility treatment of patients withPCOS. Akush Ginekol (Sofiia). 2013;52(4):25-28.
  29. Nardo LG, Bosch E, Lambalk CB, Gelbaya TA. Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee. Hum Fertil (Camb). 2013 Sep;16(3):144-150.
  30. Kovaleva Yu.V. Lechenie anovulyatornogo besplodiya u bol'nykh s sindromom polikistoznykh yaichnikov. Problemy reproduktsii. 2011; 261-262 (cpetsial'nyi vypusk VI mezhdunarodnogo kongressa po reproduktivnoi meditsine).
  31. DiLuigi AJ. et al. Gonadotropin-releasing hormone agonist induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting. Fertil Steril. 2010;94:1111-1114.
  32. Humaidan P. Agonist trigger and low dose HGC. Fertil Steril. 2011;97:529-530.
  33. Anshina M.B. i dr. Otlozhennyi perenos embrionov u zhenshchin s vysokim riskom SGYa. Materialy KhKh mezhdunarodnoi konferentsii RARCh. Reproduktivnye tekhnologii segodnya i zavtra. 2010.
  34. Popov A.A. i dr. Reproduktivnaya khirurgiya v epokhu VRT. Problemy reproduktsii. 2011; 268-269 (spetsial'nyi vypusk VI mezhdunarodnogo kongressa po reproduktivnoi meditsine).
  35. Abu Hashim H, Al-Inany H, De Vos M, Tournaye H. Three decades after Gjönnaess’s laparoscopic ovarian drilling for treatment of PCOS; what do we know? An evidence-based approach. Arch Gynecol Obstet. 2013 Aug;288(2):409-422.
  36. Radzinskii V.E., Dukhin A.O., Aleev I.A., Oparin I.S. Perspektivy reproduktivnoi khirurgii. Problemy reproduktsii. 2011; 270-271 (spetsial'nyi vypusk VI mezhdunarodnogo kongressa po reproduktivnoi meditsine).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.